Twin Lakes Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Buy |
267
+1
| +0.4% | +$525 | 0.09% | 88 |
|
|
2025
Q1 | $169K | Hold |
266
| – | – | 0.11% | 86 |
|
|
2024
Q4 | $189K | Hold |
266
| – | – | 0.12% | 87 |
|
|
2024
Q3 | $280K | Hold |
266
| – | – | 0.18% | 73 |
|
|
2024
Q2 | $280K | Hold |
266
| – | – | 0.19% | 69 |
|
|
2024
Q1 | $256K | Hold |
266
| – | – | 0.17% | 74 |
|
|
2023
Q4 | $234K | Hold |
266
| – | – | 0.16% | 77 |
|
|
2023
Q3 | $219K | Hold |
266
| – | – | 0.16% | 74 |
|
|
2023
Q2 | $191K | Sell |
266
-25
| -9% | -$18K | 0.14% | 84 |
|
|
2023
Q1 | $239K | Hold |
291
| – | – | 0.18% | 74 |
|
|
2022
Q4 | $210K | Hold |
291
| – | – | 0.16% | 77 |
|
|
2022
Q3 | $200K | Hold |
291
| – | – | 0.16% | 83 |
|
|
2022
Q2 | $172K | Hold |
291
| – | – | 0.12% | 74 |
|
|
2022
Q1 | $203K | Buy |
291
+15
| +5% | +$10.5K | 0.11% | 93 |
|
|
2021
Q4 | $174K | Sell |
276
-14
| -5% | -$8.83K | 0.09% | 105 |
|
|
2021
Q3 | $176K | Sell |
290
-37
| -11% | -$22.5K | 0.1% | 96 |
|
|
2021
Q2 | $183K | Sell |
327
-67
| -17% | -$37.5K | 0.1% | 86 |
|
|
2021
Q1 | $186K | Buy |
+394
| New | +$186K | 0.11% | 81 |
|